Cell Signaling Technology

Product Pathways - MAPK Signaling

KSR1 Antibody #4640

Applications Reactivity Sensitivity MW (kDa) Source
W H M R Mk Endogenous 100 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

KSR1 Antibody detects endogenous levels of total KSR1 protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the region surrounding Gly910 of human KSR1. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from various cells lines using KSR1 Antibody.

Background

KSR1 (kinase supressor of Ras) was identified from a genetic screen in Drosophila and C. elegans as a component of the Ras signaling pathway (1). KSR1 has a putative carboxy-terminal kinase domain that lacks a key Lys residue for phospho-group transfer. Although reports indicate that ceramide and EGF activate KSR1 (2,3), other evidence demonstrates that KSR1 regulates Raf in a kinase-independent manner (4,5). It is now widely accepted that KSR1 functions as a scaffold that binds MEK1/2 and 14-3-3 protein constitutively and binds ERK1/2 in a Ras activation-dependent manner (1,5,6). HSP70/HSP90 and p50 Cdc37 associate with the KSR1 complex to ensure its stability (5). Multiple phosphorylation sites have been identified: Ser297 and Ser392 mediate 14-3-3 binding, and putative MAPK phosphorylation sites include Thr260, Thr274 and Ser443 (6). C-TAK1 (Cdc25C-associated kinase 1) binds and phosphorylates KSR1 at Ser392 in quiescent cells (7). In response to stimuli, Ser392 is dephosphorylated by PP2A, which leads to ERK1/2 association and allows the KSR1 complex to translocate from cytosol to membrane, where the MAPK pathway is activated (8). IMP, a Ras-responsive E3 ubiquitin ligase, is also involved in interaction with KSR1 and may regulate its localization and stability (9). Very high expression levels of KSR1 inhibit MAPK signaling, whereas physiological levels promote MAPK signaling, indicating that the scaffold protein can turn signaling "on" or "off" depending on the scaffold concentration (10).

  1. Morrison, D.K. (2001) J. Cell Sci. 114, 1609-1612.
  2. Zhang, Y. et al. (1997) Cell 89, 63-72.
  3. Xing, H.R. and Kolesnick, R. (2001) J. Biol. Chem. 276, 9733-9741.
  4. Michaud, N. R. et al. (1997) Proc. Natl. Acad. Sci. USA 94, 12792-12796.
  5. Stewart, S. et al. (1999) Mol. Cell. Biol. 19, 5523-5534.
  6. Muller, J. et al. (2001) Mol. Cell 8, 983-993.
  7. Cacace, A. M. et al. (1999) Mol. Cell. Biol. 19, 229-240.
  8. Ory, S. et al. (2003) Curr. Biol. 13, 1356-1364.
  9. Matheny, S. A. et al. (2004) Nature 427, 256-260.
  10. Kortum, R.L. and Lewis, R.E. (2004) Mol Cell Biol 24, 4407-16.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Products